ADIPOQ and rheumatoid arthritis: Therefore, we analyzed a cohort of 70 treatment-naive patients with newly diagnosed RA to avoid possible bias caused by anti-rheumatic treatment and long-term disease duration, which could affect the association between adiponectin and inflammation markers.